Jon also confirming they have had a number of discussions regarding licensing, takeover and that they are not going to decide until after the FDA meeting next month. (Presumably to get the best value/outcome). Also confirmed our theory that they will be prepared to fund 2 phase 3 without any capital raisings but the likelihood of a transaction occurring from then would be increased. 2 phase 3's is fantastic but there's an opportunity for much more to be occurring and for this drug to be a 10b+ sales monster.
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Angelman
Ann: Phase 2 trial shows significant improvements in Angelman, page-52
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B |
Open | High | Low | Value | Volume |
$15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 125 | $16.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.20 | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125 | 16.150 |
1 | 1332 | 16.140 |
1 | 650 | 16.110 |
1 | 500 | 16.100 |
1 | 4108 | 16.090 |
Price($) | Vol. | No. |
---|---|---|
16.200 | 1500 | 1 |
16.290 | 10000 | 1 |
16.300 | 4108 | 1 |
16.340 | 4108 | 1 |
16.380 | 4108 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |